Arca Biopharma | ABIO - Actif À Court Terme





Actif À Court Terme Changement Date
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 31.48B 2.42B 2026-03
Arca Biopharma USD 395.25M 51.39M 2026-03
Biogen USD 9.19B 216.3M 2026-03
Brainstorm Cell Therapeutics USD 184K 123K 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Capricor Therapeutics USD 283.09M 39.85M 2026-03
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
Cytokinetics USD 839.46M 77.51M 2026-03
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Grifols EUR 5.96B 316.31M 2025-12
Laboratory Of America USD 4.56B 538.3M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
Otsuka Holdings JPY 1.6T 21.76B 2026-03
Pfizer USD 42.82B 76M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03